The European Unified Patent Court Clears Curio Seeker With Respect To Claim 1 Of EP 2697391 Asserted By 10x Genomics
The European Unified Patent Court Clears Curio Seeker With Respect To Claim 1 Of EP 2697391 Asserted By 10x Genomics
The European Unified Patent Court (UPC) today announced a finding that Curio Seeker does not infringe main claim 1 of EP 2697391 asserted by 10x Genomics (NASDAQ:TXG). The UPC has also ordered Curio Bioscience not to offer any product that would violate claim 14 of the '391 patent in France, Germany, and Sweden. Accordingly, Curio Bioscience will comply with the order and expects no impact to its commercial business.
歐洲統一專利法院（UPC）今天宣佈了一項裁決，即Curio Seeker沒有違反10x Genomics（納斯達克股票代碼：TXG）提出的第2697391號EP 2697391的主要索賠1。UPC還命令Curio Bioscience不要提供任何違反法國、德國和瑞典'391專利第14項權利要求的產品。因此，Curio Bioscience將遵守該命令，預計其商業業務不會受到影響。
The decision arises from 10x's request for provisional measures and is open to appeal. The main action remains pending.
該決定源於10x的臨時措施請求，可以上訴。主要行動仍在進行中。
譯文內容由第三人軟體翻譯。